This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Ucl Business Plc. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: The Innovative Contributions of Nishil Patel
Introduction
Nishil Patel is a prominent inventor based in London, GB. He has made significant strides in the field of gene therapy, particularly in the treatment of Haemophilia B. With a total of 2 patents to his name, Patel's work is paving the way for advancements in medical science.
Latest Patents
One of Patel's latest patents focuses on a new, more potent coagulation Factor IX (FIX) expression cassette for gene therapy of Haemophilia B (HB). This invention discloses a vector for expressing factor IX protein, which includes a promoter, a nucleotide sequence encoding for a functional factor IX protein, and an intron sequence. The intron sequence is strategically positioned between exon 1 and exon 2 of the nucleotide sequence, boasting at least 80% identity to the sequence of SEQ ID NO. 1 as disclosed in the patent.
Career Highlights
Nishil Patel is currently associated with UCL Business Plc, where he continues to contribute to innovative research and development in the field of gene therapy. His work is instrumental in addressing critical health challenges associated with coagulation disorders.
Collaborations
Patel collaborates with notable colleagues, including Jenny McIntosh and Amit Nathwani, who share his commitment to advancing medical technology and improving patient outcomes.
Conclusion
Nishil Patel's contributions to gene therapy exemplify the impact of innovation in healthcare. His patents and collaborative efforts are vital in the ongoing quest to enhance treatment options for patients with Haemophilia B.